, Hisaya Kawate 1) , Chitose Matsuzaki 1) , Ryuichi Sakamoto 1) , Ichiro Abe 1) , Kimitaka Shibue 1) , Michiko Kohno 1) , Masahiro Adachi 1) , Keizo Ohnaka 2) , Masatoshi Nomura 1) and Ryoichi Takayanagi 1) by cardiac hypertrophy, hypertension, valve abnormalities and arrhythmias [1, 3] . Vascular alterations have also been demonstrated in patients with acromegaly even in the absence of classical risk factors for atherosclerosis, indicating direct effects of excess GH and IGF-I on vascular function [2] [3] [4] .
Arterial stiffness is increasingly recognized as a predictive marker for cardiovascular events. Higher arterial stiffness is associated with an increased risk of future cardiovascular events and all-cause mortality. For assessment of arterial stiffness, the carotid-femoral pulse wave velocity (cfPWV) is considered to be the gold standard [5, 6] . A large amount of evidence indicates that the cfPWV is a strong predictor of future cardiovascular events. However, the cfPWV has been shown to have a strong dependence on the blood pressure [7, 8] .
The cardio-ankle vascular index (CAVI) has recently confirmed by magnetic resonance imaging. Hypertension was defined as blood pressure 140/90 mmHg or higher or taking hypertensive medication. Diabetes mellitus was defined as glycosylated hemoglobin (HbA1c) ≥ 6.5%, fasting plasma glucose level ≥ 126 mg/dL, or receiving medical therapy for diabetes mellitus. Dyslipidemia was defined as low-density lipoprotein (LDL)-cholesterol level ≥ 140 mg/dL, high-density lipoprotein (HDL)-cholesterol level < 40 mg/dL, triglyceride (TG) ≥ 140 mg/dL, or taking lipidlowering therapy. Obesity was defined as body mass index (BMI) ≥ 25 kg/m 2 .
Measurement of the CAVI
The CAVI was measured automatically using a VaSera VS-1500N instrument (Fukuda Denshi Co. Ltd., Tokyo, Japan) as previously described [9] . Briefly, patients were placed the supine position and an electrocardiogram and the heart sound were monitored. To detect brachial and ankle pulse waves, cuffs were applied to the bilateral upper arms and ankles and the pressure of the cuffs was kept low at 30-50 mmHg to ensure a minimal effect of cuff pressure on the hemodynamics. The blood pressure was then measured at the brachial artery.
The CAVI was calculated using the formula, CAVI=a{(2ρ/ΔP)×ln(Ps/Pd)PWV 2 }+b, where Ps is the systolic blood pressure, Pd is the diastolic blood pressure, PWV is the pulse wave velocity, ΔP is Ps-Pd, ρ is the blood density, and a and b are constants. The brachial-ankle pulse wave velocity (baPWV) and ankle brachial pressure index (ABI) were measured according to a previous report [9] .
Carotid artery study
The intima-media thickness (IMT) of the carotid arteries was measured at a 10-MHz scanning frequency in the B-mode using an ultrasonic diagnostic equipment (SDU-2200; Shimadzu Co. Ltd., Kyoto, Japan) that was programmed with the IMT measurement software Intimascope (Media Cross Co. Ltd., Tokyo, Japan). This software is able to automatically recognize the edges of the internal and external membranes of blood vessels and automatically measure the distance at a sub-pixel level, using a three-dimensional polynomial measurement formula [13] . Images were obtained in the 20-mm proximal region to the origin of the bulb at the far wall of the right common carotid artery. The average IMT was obtained as the average value of 250 computer-based points in the region.
been developed, and reflects the arterial stiffness from the heart to the ankles [9] . The CAVI is calculated based on the stiffness parameter β, which is less influenced by the blood pressure than the PWV, and has adequate reproducibility for clinical use [9] . It has been reported that the CAVI is a useful parameter for detecting systemic arteriosclerosis as well as the cfPWV [9] [10] [11] . As arteriosclerosis progresses, the CAVI becomes significantly higher [9] [10] [11] .
In the present study, we evaluated the arterial stiffness of patients with acromegaly using the CAVI. Based on previous results for the PWV, we inferred that the CAVI would increase in patients with acromegaly, similar to the case for the PWV. Contrary to our expectation, all the patients with acromegaly showed reduced arterial stiffness compared with age-and sexmatched controls. We also found that the CAVI was negatively correlated with the serum IGF-I level. After treatment with octreotide and/or transsphenoidal surgery, the CAVI showed a marked increase accompanied by a decrease in the serum IGF-I level. Our findings indicate that the CAVI would be a good indicator for reflecting arteriovascular alterations and evaluating therapeutic effects in patients with acromegaly.
Subjects and Methods

Patients
We examined a total of 21 patients with acromegaly, comprising five patients with untreated active acromegaly (all females; age range: 26-63 years), one patient treated with medication only (female; age: 66 years) and 15 patients who underwent transsphenoidal surgery (six males and nine females; age range: 28-72 years). Among the 15 patients treated with surgery, 10 received additional therapies with dopamine agonists and/or somatostatin analogs. Active acromegaly (n=9) was defined as both an increased IGF-I for age and gender (Z-score ≥ 2 SD) and a mean GH value greater than 2 ng/mL in treated and untreated patients. Controlled acromegaly (n=10) was defined by both normalized IGF-I (Z-score < 2 SD) and a mean GH value of 2 ng/ mL or less. Patients with discordant IGF-I and GH values (n=2) were considered as not controlled [12] .
The diagnosis of acromegaly was performed on the basis of typical clinical features of acromegaly, namely increased serum GH and IGF-I levels, and failure to suppress the GH level below 1 ng/mL after a 75-g oral glucose load. In all patients, a pituitary adenoma was patient's data and the mean value by the standard deviation (SD). All statistical data were expressed as the mean ± SD. All statistical analyses were performed using Microsoft Excel 2010 software. Values of P≤0.05 were considered statistically significant.
Results
To evaluate arterial stiffness in patients with acromegaly, a non-invasive vascular evaluation was performed using the CAVI. We studied a total of 21 patients diagnosed with acromegaly, comprising five untreated patients, one patient treated with medication and 15 patients who underwent transsphenoidal surgery. In this study, all 21 acromegaly patients showed lower CAVI values (negative Z-scores) than age-and sex-matched controls, regardless of whether they underwent surgery, indicating that the arterial stiffness was decreased in patients with acromegaly (Table 1) . A significant negative correlation (r=-0.467) between
Biochemical assays
The serum IGF-I level was measured by immunoradiometric assay (FUJIFILM RI Pharma Co. Ltd., Tokyo, Japan). The serum GH level was measured by radioimmunoassay. The serum concentrations of HDLcholesterol, LDL-cholesterol, TG, fasting blood glucose and HbA1c were measured by standard procedures.
Statistical analyses
The Z-scores of the patients were obtained based on the IGF-I and CAVI data for age-and sex-matched control groups. The data for IGF-I in a healthy control group were provided from the Japanese research group for Research on Specific Diseases "Hypothalamo-Pituitary Dysfunction" from the Ministry of Health, Labour and Welfare, Japan. The reference values for the CAVI at each age were provided by Fukuda Denshi Co. Ltd., and were obtained from more than 30,000 healthy Japanese adults referred for health examinations [9] . Each Z-score was calculated by dividing the difference between the CAVI, cardio-ankle vascular index; baPWV, brachial-ankle pulse wave velocity; IMT, intima-media thickness; SBP, systolic blood pressure; DBP, diastolic blood pressure; Add Tx, additional therapy; DA, dopamine agonists; SA, somatostatin analogs the serum IGF-I level and the CAVI was found in these 21 patients with acromegaly (P=0.032) (Fig. 1) . There was no relationship between IGF-I and other vascular parameters, such as the baPWV and IMT. The ABI values of all the patients were in the normal range (data not shown). Traditional risk factors for atherosclerosis, such as hypertension, diabetes mellitus, dyslipidemia, obesity and smoking are known to influence arterial stiffness. We evaluated the relationship between CAVI and these risk factors. Interestingly, CAVI was significantly lower in patients with dyslipidemia than in those without dyslipidemia. There was no significant correlation between other risk factors and CAVI in these patients (Table 2) .
To evaluate the relationship between control status of acromegaly and CAVI, comparison of CAVI values in between active and controlled acromegaly were performed. As shown in Fig. 2 , patients with active acro- megaly showed significantly lower CAVI than controlled acromegalic patients. We were able to follow up two patients with active acromegaly and sequentially measured the CAVI and serum IGF-I before and after treatment. The clinical courses of these patients (cases 3 and 4) are summarized in Fig. 3 . Preoperative treatment with octreotide in these patients reduced their serum IGF-I levels, accompanied by CAVI elevation (Fig. 3A and 3B) . After transsphenoidal surgery, the serum IGF-I levels Active disease (n=9) was defined as both an increased IGF-I for age and gender (Z-score ≥ 2 SD) and a mean GH value greater than 2 ng/mL in treated and untreated patients. Controlled disease (n=10) was defined by both normalized IGF-I (Z-score < 2 SD) and a mean GH value of 2 ng/mL or less. value does not depend on blood pressure. It has also been indicated that CAVI can evaluate vascular smooth muscle cell contraction including vascular endothelial function in addition to the organic components of the arterial wall [9] . Such difference in measurement principles between PWV and CAVI may cause the discrepancy of arterial stiffness obtained by these two methods in patients with acromegaly. In our present study, the simultaneously measured baPWV values in patients with acromegaly were also lower than the baPWV cut-off point (1,400 cm/s) for risk stratification by the Framingham score and discrimination of patients with atherosclerotic cardiovascular disease [21] . In the late stage of acromegaly, it is known that peripheral vascular resistance is increased owing to persistent hypertension, diabetes mellitus, lipid abnormalities and aging. Our results showing reduced arterial stiffness in patients with acromegaly may be associated with the involvement of relatively earlier stage acromegalic patients compared with the previous studies.
It has been reported that a high CAVI is observed in arteriosclerotic diseases and CAVI is related to coronary risk factors such as hypertension, diabetes mellitus, dyslipidemia and smoking [9] . However, in the present study, patients with dyslipidemia showed lower CAVI than those without dyslipidemia. Although CAVI and dyslipidemia are not closely connected, lipid-lowering agents are known to decrease CAVI [9, 22, 23] . In our study, 7 of 11 (64%) patients with dyslipidemia were defined as active acromegaly, whereas only 2 of 9 (22%) patients without dyslipidemia were active acromegaly. These results indicate that in patients with acromegaly, the GH/IGF-I excess would be more influential on arterial stiffness than dyslipidemia.
Our present results showed that the CAVI values in patients with acromegaly promptly increased after the treatment with octreotide and/or transsphenoidal surgery, having a significant inverse correlation with the serum level of IGF-I (Fig. 3) . On the other hand, CAVI remained lower than age-and gender-matched controls even in acromegalic patients whose serum IGF-I levels were normalized after the treatment. These results imply that arterial stiffness in patients with acromegaly includes both reversible and irreversible components. It has been shown that arterial stiffness is determined by a complex interaction between stable and dynamic changes involving structural and cellular elements of the vessel wall [24, 25] . The reversible components in in both patients decreased further and the CAVI values showed further increases compared with the values before the surgery (Fig. 3A and 3B) . The baPWV value increased in case 3 (Fig. 3A) and remained unchanged in case 4 (Fig. 3B) . Although a significant reduction in the IMT after treatment was observed in both patients, there was no significant correlation between the serum IGF-I level and the IMT score (Fig. 3A and 3B ). These findings indicate that the CAVI can be a useful parameter that reflects the present vascular status and would be useful for evaluating therapeutic effects in patients with acromegaly.
Discussion
In the present study, we have demonstrated a decrease in arterial stiffness in patients with acromegaly using the CAVI, which was negatively correlated with the serum IGF-I level. After treatment of acromegaly, the reduction in the serum IGF-I level was accompanied by elevation of the CAVI.
It has been reported that the GH/IGF-I axis reduces systemic vascular resistance via nitric oxide (NO) production by endothelial and vascular smooth muscle cells [14] [15] [16] . NO formation is decreased in patients with GH deficiency and replacement of GH increases NO production accompanied by a decrease in vascular resistance [17, 18] . These vasodilatory effects of GH and IGF-I would be consistent with the decrease in arterial stiffness observed in acromegalic patients with excess GH and IGF-I in the present study. The rapid increase in arterial stiffness indicated by an increased CAVI after treatment with octreotide or surgery in the present study is thought to reflect that the treatment abolished the excessive NO production in response to oversecretion of GH and IGF-I in patients with acromegaly.
Previous studies using the PWV or augmentation index demonstrated that patients with acromegaly show higher arterial stiffness than control subjects [19, 20] . Unlike these previous findings, our study revealed that all patients with active or cured acromegaly showed lower arterial stiffness evaluated by the CAVI than age-and sex-matched controls. PWV is calculated by dividing the distance between two measurement points by the transit time and is influenced by blood pressure level at the time of PWV measurement [5, 6] . On the other hand, CAVI is originally derived from stiffness β which represents the blood pressure change required to expand the diameter of the artery; therefore this arterial stiffness consist of vascular endothelial function and vascular smooth muscle cell tone influenced by vasoactive mediators such as NO, endothelin-1 and angiotensin II. The irreversible components in arterial stiffness are related to the quality and quantity of extracellular matrix components of vascular walls such as elastin and collagen. Since IGF-I is known to upregulate aortic elastogenesis, persistence of GH/IGF-I excess in patients with acromegaly may increase the elastin to collagen ratio, resulting in reduction of arterial stiffness [26, 27] .
Similar to patients with acromegaly accompanied by excess GH and IGF-I, patients with GH deficiency have an increased cardiovascular mortality. It has been shown that patients with GH deficiency have increased IMT, atheromatous plaques and increased arterial stiffness compared with control subjects [16] [17] [18] 28] . Significant improvement of these vascular abnormalities can be observed after replacement of GH. On the other hand, less consistent data have been reported about the vascular alterations in patients with acromegaly [1] [2] [3] . Since the prevalence of well-defined atherosclerotic plaques in patients with acromegaly is not higher than that in control subjects, the vascular alterations induced by excess GH seem to differ from the typical atherosclerotic changes caused by lifestyle diseases such as obesity, hypertension, diabetes mellitus and dyslipidemia. However, in the late stage of acromegaly, complications such as hypertension, diabetes mellitus and dyslipidemia become evident and have significant effects on vascular function, making it too complicated to evaluate the effects of the GH/IGF-I axis on the cardiovascular system.
It has also been reported that reduced endothelium-dependent flow-mediated dilatation (FMD), which is a marker of endothelial dysfunction, is observed in patients with acromegaly. The FMD is improved in cured acromegalic patients [1] [2] [3] . According to previous studies of acromegalic patients, vascular tone would be decreased through NO production in response to excess GH and IGF-I [15] [16] [17] [18] [19] . Such constitutive vascular relaxation in acromegalic patients may lower the flow-mediated arterial caliber changes.
In summary, we have demonstrated reduced arterial stiffness in patients with acromegaly using the CAVI. The CAVI showed a significant negative correlation with the serum IGF-I level. After treatment of these patients with acromegaly, the decrease in the serum IGF-I level was accompanied by CAVI elevation. These findings indicate that the CAVI is a useful indicator for evaluating vascular alterations in patients with acromegaly. The GH/IGF-I axis would be one of the important regulators of arterial stiffness.
